OPTIONS DE TRAITEMENT DE LA MALADIE DE FABRY
- 专利权人:
- AMICUS THERAPEUTICS, INC.;NATIONAL INSTITUTES OF HEALTH
- 发明人:
- KANESKI, CHRISTINE,SHIN, SANG-HOON,MURRAY, GARY,LUDWIG, KARIN,LOCKHART, DAVID,CASTELLI, JEFF
- 申请号：
- CA2652553
- 公开号：
- CA2652553C
- 申请日:
- 2007.05.16
- 申请国别(地区):
- CA
- 年份:
- 2020
- 代理人:
- 摘要：
- Provided are uses of 1-deoxygalactonojirimycin or a salt for treating Fabrydisease and/orfor enhancing .alpha.-galactosidase A activity.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- NAPHTHYRIDINE DERIVATIVES USEFUL AS ALPHA-V-BETA-6 INTEGRIN ANTAGONISTS
- Naphthyridine derivatives useful as alpha-v-beta-6 integrin antagonists
- -V--6 NAPHTHYRIDINE DERIVATIVES USEFUL AS ALPHA-V-BETA-6 INTEGRIN ANTAGONISTS
- -V--6 NAPHTHYRIDINE DERIVATIVES USEFUL AS ALPHA-V-BETA-6 INTEGRIN ANTAGONISTS
- DÉRIVÉS DE NAPHTYRIDINE UTILES COMME ANTAGONISTES DE L'INTÉGRINE ALPHA-V-BÊTA-6
